ATLANTA, GA - SunLink Health Systems Inc. (NYSE American: SSY), a healthcare services provider, announced the results of their annual shareholder meeting held on June 28, 2024. Shareholders voted to elect three management-nominated directors to the company's board for two-year terms.
Robert M. Thornton, Jr., Dr. Steven J. Baileys, Jr., and Gene E. Burleson were elected with 2,568,294, 2,692,389, and 2,599,505 votes respectively. Votes withheld ranged from 707,296 to 831,391, with broker non-votes totaling 1,250,813 for each nominee. These elected directors will serve until the 2025 annual meeting, while C. Michael Ford (NYSE:F) and Mark J. Stockslager will continue their terms until the 2024 annual meeting.
The non-binding advisory vote on executive compensation was approved with 2,762,502 votes for, 433,424 against, and 203,759 abstentions. Furthermore, shareholders approved a three-year frequency for future non-binding votes on executive compensation. The tally for this proposal was 1,683,695 for one year, 4,237 for two years, 1,704,447 for three years, and 7,306 abstentions.
These decisions were made during the company's annual meeting and are stated in the company's 8-K filing with the Securities and Exchange Commission. The filing also included the company's financial statements and exhibits.
SunLink Health Systems, based in Atlanta, Georgia, operates under the healthcare sector, specifically in general medical and surgical hospitals. The company's business address and contact information remain unchanged.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.